Pfizer

{
  "facts": [
    {
      "date": "2026-08-04",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 04/08/2026 - Annexes du Moniteur belge",
      "value": "04/08/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-28",
      "type": "filing",
      "quote": "D\u00E9pos\u00E9/Re\u00E7u le 28 JUIL. 2026",
      "value": "28/07/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: R\u00E9vocation et nomination d\u0027administrateurs",
      "value": "R\u00E9vocation et nomination d\u0027administrateurs",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-01",
      "type": "general_meeting",
      "quote": "Extrait des d\u00E9cisions prises par l\u0027actionnaire unique de la Soci\u00E9t\u00E9 le 1er juillet 2026",
      "value": "01/07/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_resignation",
      "quote": "L\u0027actionnaire unique d\u00E9cide de r\u00E9voquer Monsieur Guy Van den Meersche ... en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9, et ce avec effet \u00E0 la date de ce jour.",
      "value": {
        "role": "administrateur",
        "end_date": "2026-07-01"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "administrateur",
        "end_date": "01/07/2026"
      }
    },
    {
      "type": "officer_resignation",
      "quote": "L\u0027actionnaire unique d\u00E9cide de r\u00E9voquer ... Madame Anne De Backer en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9, et ce avec effet \u00E0 la date de ce jour.",
      "value": {
        "role": "administrateur",
        "end_date": "2026-07-01"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "administrateur",
        "end_date": "01/07/2026"
      }
    },
    {
      "type": "officer_discharge",
      "quote": "L\u0027actionnaire unique d\u00E9cide de donner d\u00E9charge provisoire \u00E0 Monsieur Guy Van den Meersche ... pour l\u0027exercice de leur mandat d\u0027administrateur",
      "value": {
        "role": null
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": "provisoire"
    },
    {
      "type": "officer_discharge",
      "quote": "L\u0027actionnaire unique d\u00E9cide de donner d\u00E9charge provisoire ... \u00E0 Madame Anne De Backer pour l\u0027exercice de leur mandat d\u0027administrateur",
      "value": {
        "role": null
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": "provisoire"
    },
    {
      "date": "2026-07-01",
      "type": "officer_appointment",
      "quote": "L\u0027actionnaire unique d\u00E9cide de nommer Kathleen Commers ... en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9 avec effet \u00E0 compter de la date des pr\u00E9sentes r\u00E9solutions. L\u0027administrateur susmentionn\u00E9 est nomm\u00E9 pour une dur\u00E9e de six ans.",
      "value": {
        "role": "administrateur",
        "term": "six ans",
        "start_date": "2026-07-01"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "administrateur",
        "term": "six ans",
        "start_date": "01/07/2026"
      }
    },
    {
      "type": "mandate_compensation",
      "quote": "Le mandat de l\u0027administrateur n\u0027est pas r\u00E9mun\u00E9r\u00E9.",
      "value": "non r\u00E9mun\u00E9r\u00E9",
      "object": "e1",
      "subject": "e4"
    },
    {
      "type": "power_of_attorney",
      "quote": "L\u0027actionnaire unique d\u00E9cide de donner mandat \u00E0 Ma\u00EEtre Micha\u00EBl Heene, Ma\u00EEtre Hannah De Schrijver, Ma\u00EEtre H\u00E9l\u00E8ne Carbonnelle, Madame M\u00E9lanie Dangreau, ou tout autre avocat ou juriste du cabinet d\u0027avocats DLA Piper UK LLP ... pour accomplir au nom et pour le compte de la Soci\u00E9t\u00E9 toutes les formalit\u00E9s de publication l\u00E9gale",
      "value": "accomplir toutes les formalit\u00E9s de publication l\u00E9gale relatives aux r\u00E9solutions adopt\u00E9es lors de la pr\u00E9sente assembl\u00E9e g\u00E9n\u00E9rale",
      "object": "e1",
      "subject": "e7"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 4816,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer",
      "attrs": {
        "seat": "Boulevard de la Plaine 17, 1050 Ixelles",
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Guy Van den Meersche",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Anne De Backer",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "Kathleen Commers",
      "attrs": {
        "address": "si\u00E8ge de la Soci\u00E9t\u00E9"
      }
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "R\u00E9ginald Decraene",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "person",
      "name": "Laurence Einsweiler",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "org",
      "name": "DLA Piper UK LLP",
      "attrs": {
        "address": "rue aux Laines 70, 1000 Bruxelles"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Micha\u00EBl Heene",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Hannah De Schrijver",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "H\u00E9l\u00E8ne Carbonnelle",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "M\u00E9lanie Dangreau",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "type": "filing",
      "quote": "D\u00E9pos\u00F3 / Re\u00E7u le 26 MARS 2026",
      "value": "2026-03-26",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 02/04/2026 - Annexes du Moniteur belge",
      "value": "2026-04-02",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: R\u00E9vocation et d\u00E9l\u00E9gation de pouvoirs sp\u00E9ciaux",
      "value": "R\u00E9vocation et d\u00E9l\u00E9gation de pouvoirs sp\u00E9ciaux",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_resignation",
      "quote": "Le conseil d\u0027administration d\u00E9cide de r\u00E9voquer, avec effet au 1er septembre 2025, le mandat d\u00E9l\u00E9gu\u00E9 \u00E0 Madame Anne De Backer le 1er juin 2010 dans sa fonction de MR MOS Lead",
      "value": {
        "role": "MR MOS Lead",
        "effective_date": "2025-09-01"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "type": "officer_appointment",
      "quote": "Le conseil d\u0027administration d\u00E9cide d\u0027accorder un nouveau mandat avec effet au 1er septembre 2025 \u00E0 Madame Anne De Backer dans sa fonction de Director People Experience Belux",
      "value": {
        "role": "Director People Experience Belux",
        "powers": [
          "Le pouvoir de signer et ex\u00E9cuter, au nom et pour compte de la Soci\u00E9t\u00E9, tout document n\u00E9cessaire ou utile \u00E0 l\u0027embauche ou au licenciement du personnel, y compris, mais sans limitation, les contrats de travail et lettres de licenciement, et en ce compris les licenciements pour motifs graves",
          "Le pouvoir de signer et ex\u00E9cuter au nom de la Soci\u00E9t\u00E9 tout document utile \u00E0 la gestion des salaires, bonus, et autres conditions et compensations pour le personnel"
        ],
        "effective_date": "2025-09-01"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "type": "power_of_attorney",
      "quote": "Le conseil d\u0027administration d\u00E9cide de donner mandat \u00E0 Ma\u00EEtre Micha\u00EBl Heene... chacun d\u0027eux pouvant agir seul et avec pouvoir de substitution, pour accomplir au nom et pour le compte de la Soci\u00E9t\u00E9 toutes les formalit\u00E9s de publication l\u00E9gale relatives aux r\u00E9solutions adopt\u00E9es",
      "value": {
        "scope": "accomplir au nom et pour le compte de la Soci\u00E9t\u00E9 toutes les formalit\u00E9s de publication l\u00E9gale relatives aux r\u00E9solutions adopt\u00E9es",
        "acting_alone": true,
        "substitution": true
      },
      "object": "e1",
      "subject": "e3"
    },
    {
      "type": "power_of_attorney",
      "quote": "Le conseil d\u0027administration d\u00E9cide de donner mandat \u00E0... Ma\u00EEtre Hannah De Schrijver... chacun d\u0027eux pouvant agir seul et avec pouvoir de substitution, pour accomplir au nom et pour le compte de la Soci\u00E9t\u00E9 toutes les formalit\u00E9s de publication l\u00E9gale relatives aux r\u00E9solutions adopt\u00E9es",
      "value": {
        "scope": "accomplir au nom et pour le compte de la Soci\u00E9t\u00E9 toutes les formalit\u00E9s de publication l\u00E9gale relatives aux r\u00E9solutions adopt\u00E9es",
        "acting_alone": true,
        "substitution": true
      },
      "object": "e1",
      "subject": "e4"
    },
    {
      "type": "power_of_attorney",
      "quote": "Le conseil d\u0027administration d\u00E9cide de donner mandat \u00E0... Ma\u00EEtre H\u00E9l\u00E8ne Carbonnelle... chacun d\u0027eux pouvant agir seul et avec pouvoir de substitution, pour accomplir au nom et pour le compte de la Soci\u00E9t\u00E9 toutes les formalit\u00E9s de publication l\u00E9gale relatives aux r\u00E9solutions adopt\u00E9es",
      "value": {
        "scope": "accomplir au nom et pour le compte de la Soci\u00E9t\u00E9 toutes les formalit\u00E9s de publication l\u00E9gale relatives aux r\u00E9solutions adopt\u00E9es",
        "acting_alone": true,
        "substitution": true
      },
      "object": "e1",
      "subject": "e5"
    },
    {
      "type": "power_of_attorney",
      "quote": "Le conseil d\u0027administration d\u00E9cide de donner mandat \u00E0... Madame M\u00E9lanie Dangreau... chacun d\u0027eux pouvant agir seul et avec pouvoir de substitution, pour accomplir au nom et pour le compte de la Soci\u00E9t\u00E9 toutes les formalit\u00E9s de publication l\u00E9gale relatives aux r\u00E9solutions adopt\u00E9es",
      "value": {
        "scope": "accomplir au nom et pour le compte de la Soci\u00E9t\u00E9 toutes les formalit\u00E9s de publication l\u00E9gale relatives aux r\u00E9solutions adopt\u00E9es",
        "acting_alone": true,
        "substitution": true
      },
      "object": "e1",
      "subject": "e6"
    },
    {
      "type": "power_of_attorney",
      "quote": "Le conseil d\u0027administration d\u00E9cide de donner mandat \u00E0... tout autre avocat ou juriste du cabinet d\u0027avocats DLA Piper UK LLP... chacun d\u0027eux pouvant agir seul et avec pouvoir de substitution, pour accomplir au nom et pour le compte de la Soci\u00E9t\u00E9 toutes les formalit\u00E9s de publication l\u00E9gale relatives aux r\u00E9solutions adopt\u00E9es",
      "value": {
        "scope": "accomplir au nom et pour le compte de la Soci\u00E9t\u00E9 toutes les formalit\u00E9s de publication l\u00E9gale relatives aux r\u00E9solutions adopt\u00E9es",
        "acting_alone": true,
        "substitution": true
      },
      "object": "e1",
      "subject": "e7"
    }
  ],
  "act_meta": {
    "model_id": 40,
    "extractor": "open-capture-27b-v3",
    "ocr_chars": 3854,
    "truncated": false,
    "needs_verify": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer",
      "attrs": {
        "seat": "Boulevard de la Plaine 17, 1050 Ixelles",
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Anne De Backer",
      "attrs": {
        "role": "Director People Experience Belux"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Micha\u00EBl Heene",
      "attrs": {
        "role": "Ma\u00EEtre"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "Hannah De Schrijver",
      "attrs": {
        "role": "Ma\u00EEtre"
      }
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "H\u00E9l\u00E8ne Carbonnelle",
      "attrs": {
        "role": "Ma\u00EEtre"
      }
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "person",
      "name": "M\u00E9lanie Dangreau",
      "attrs": {
        "role": "Mandataire"
      }
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "org",
      "name": "DLA Piper UK LLP",
      "attrs": {
        "type": "cabinet d\u0027avocats"
      }
    }
  ]
}

{
  "facts": [
    {
      "date": "2026-01-27",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 27/01/2026",
      "value": "27/01/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-01-20",
      "type": "filing",
      "quote": "neergelegd/ontvangen op 20 JAN. 2026",
      "value": "20/01/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2025-12-01",
      "type": "permanent_representative",
      "quote": "Pfizer N.V. (BE 0401.994.823) heeft als nieuwe vaste vertegenwoordiger vanaf 01/12/2025 de heer R\u00E9ginald Decraene",
      "value": {
        "start_date": "01/12/2025"
      },
      "object": "e2",
      "subject": "e3"
    },
    {
      "type": "officer_resignation",
      "quote": "in opvolging van de heer David Lepoittevin",
      "value": {
        "role": "vaste vertegenwoordiger",
        "end_date": "2025-12-01"
      },
      "object": "e2",
      "subject": "e4",
      "_value_raw": {
        "role": "vaste vertegenwoordiger",
        "end_date": "01/12/2025"
      }
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1166,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Kantersteen 47, 1000 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer N.V.",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "R\u00E9ginald Decraene",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "David Lepoittevin",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "date": "2026-01-27",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 27/01/2026",
      "value": "27/01/2026",
      "object": null,
      "subject": null
    },
    {
      "date": "2026-01-20",
      "type": "filing",
      "quote": "neergetegd/ontvangen op 20 JAN. 2026",
      "value": "20/01/2026",
      "object": null,
      "subject": null
    },
    {
      "date": "2025-12-01",
      "type": "permanent_representative",
      "quote": "Pfizer S.A. (BE 0401.994.823) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 01/12/2025 Monsieur R\u00E9ginald Decraene",
      "value": {
        "start_date": "01/12/2025"
      },
      "object": "e1",
      "subject": "e2"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1153,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer S.A.",
      "attrs": {}
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "R\u00E9ginald Decraene",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "David Lepoittevin",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "address": "Cantersteen 47, 1000 Bruxelles",
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    }
  ]
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "David Lepoittevin",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-12-01",
      "evidence_quote": "L\u0027actionnaire unique d\u00E9cide de r\u00E9voquer Monsieur David Lepoittevin, en qualit\u00E9 d\u0027administrateur et d\u0027administrateur d\u00E9l\u00E9gu\u00E9 de la Soci\u00E9t\u00E9, et ce avec effet au 1er d\u00E9cembre 2025. L\u0027actionnaire unique d\u00E9cide de donner d\u00E9charge provisoire \u00E0 Monsieur David Lepoittevin pour l\u0027exercice de son mandat d\u0027adm",
      "discharge_granted": true
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "R\u00E9ginald Decraene",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-12-01",
      "evidence_quote": "L\u0027actionnaire unique d\u00E9cide de nommer Monsieur R\u00E9ginald Decraene, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9, boulevard de la Plaine 17 1050 Ixelles, en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9, pour une p\u00E9riode de six ans, et ce avec effet au 1er d\u00E9cembre 2025."
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "R\u00E9ginald Decraene",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-12-01",
      "evidence_quote": "Le conseil d\u0027administration d\u00E9cide, conform\u00E9ment \u00E0 l\u0027article 7:121 du Code des soci\u00E9t\u00E9s et des associations et \u00E0 l\u0027article 16 des statuts de la Soci\u00E9t\u00E9, de d\u00E9l\u00E9guer la gestion journali\u00E8re de la Soci\u00E9t\u00E9 ainsi que la repr\u00E9sentation de la Soci\u00E9t\u00E9 dans le cadre de cette gestion \u00E0 Monsieur R\u00E9ginald Decra"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "PFIZER",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Laurence Einsweiler",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-05-21",
      "evidence_quote": "L\u0027actionnaire unique d\u00E9cide de renouveler le mandat de Madame Laurence Einsweiler, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9, boulevard de la Plaine 17, 1050 Bruxelles, en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, avec effet \u00E0 compter de ce jour et ce pour une dur\u00E9e de six ans"
    },
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Steven Veyt",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0419122548",
        "name": "KPMG R\u00E9viseurs d\u0027Entreprises SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2025-05-21",
      "evidence_quote": "L\u0027actionnaire unique d\u00E9cide de renouveler le mandat de KPMG R\u00E9viseurs d\u0027Entreprises SRL, dont le si\u00E8ge est \u00E9tabli Luchthaven Brussel Nationaal 1K \u00E0 1930 Zaventem (Belgique), repr\u00E9sent\u00E9e par Monsieur Steven Veyt, r\u00E9viseur d\u0027entreprise (A02579), et enregistr\u00E9e aupr\u00E8s de la Banque-Carrefour des Entrepr"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "PFIZER",
    "legal_form": "SA"
  }
}

{
  "facts": [
    {
      "date": "2025-04-04",
      "type": "publication",
      "quote": "04/04/2025",
      "value": "04/04/2025",
      "object": null,
      "subject": "e1"
    },
    {
      "date": null,
      "type": "filing",
      "quote": "neergelegd/ontvangen op 28 MAIT 2025",
      "value": "28/05/2025",
      "object": null,
      "subject": "e1",
      "date_suspect": "2025-05-28"
    },
    {
      "date": "2025-02-07",
      "type": "permanent_representative",
      "quote": "Janssen-Cilag N.V. (BE 0415.283.427) heeft als nieuwe vaste vertegenwoordiger vanaf 07/02/2025 mevrouw Roxana Botea",
      "value": {
        "start_date": "07/02/2025"
      },
      "object": "e2",
      "subject": "e3"
    },
    {
      "date": "2025-02-01",
      "type": "permanent_representative",
      "quote": "Pfizer N.V. (BE 0401.994.823) hepft als nieuwe vaste vertegenwoordiger vanaf 01/02/2025 de heer David Lepoittevin",
      "value": {
        "start_date": "01/02/2025"
      },
      "object": "e5",
      "subject": "e6"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "postfix": [
      "filing date 2025-05-28 outside [pub-60d, pub] -\u003E nulled (garbled stamp?)"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1313,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Kantersteen 47, 1000 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag N.V.",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Roxana Botea",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "Marleen Hoebus",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer N.V.",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "person",
      "name": "David Lepoittevin",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "An Van Gerven",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "date": "2025-04-04",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 04/04/2025",
      "value": "04/04/2025",
      "object": null,
      "subject": null
    },
    {
      "date": "2025-03-28",
      "type": "filing",
      "quote": "naergelegd/ontvangen.o\u0440 28 MAART 2025",
      "value": "28/03/2025",
      "object": null,
      "subject": null
    },
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: Nomination nouveaux repr\u00E9sentants permanents des administrateurs",
      "value": "Nomination nouveaux repr\u00E9sentants permanents des administrateurs",
      "object": null,
      "subject": null
    },
    {
      "date": "2025-02-07",
      "type": "permanent_representative",
      "quote": "Janssen-Cilag S.A. (BE 0415.283.427) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 07/02/2025 Madame Roxana Botea",
      "value": {
        "start_date": "07/02/2025"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "date": "2025-02-01",
      "type": "permanent_representative",
      "quote": "Pfizer S.A. (BE 0401.994.823) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 01/02/2025 Monsieur David Lepoittevin",
      "value": {
        "start_date": "01/02/2025"
      },
      "object": "e3",
      "subject": "e4"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1329,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag S.A.",
      "attrs": {}
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Roxana Botea",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer S.A.",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "David Lepoittevin",
      "attrs": {}
    }
  ]
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "An Van Gerven",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-10-17",
      "evidence_quote": "L\u0027actionnaire unique d\u00E9cide de r\u00E9voquer Madame An Van Gerven, en qualit\u00E9 d\u0027administrateur d\u00E9l\u00E9gu\u00E9 de la Soci\u00E9t\u00E9, et ce avec effet \u00E0 partir du 17 octobre 2024. L\u0027actionnaire unique d\u00E9cide de donner d\u00E9charge provisoire \u00E0 Madame An Van Gerven pour l\u0027exercice de son mandat d\u0027administrateur de la Soci\u00E9t\u00E9",
      "discharge_granted": true
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "David Lepoittevin",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-02-01",
      "evidence_quote": "L\u0027actionnaire unique d\u00E9cide de nommer Monsieur David Lepoittevin, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9, boulevard de la Plaine 17 1050 Ixelles, en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9, pour une p\u00E9riode de six ans, et ce avec effet \u00E0 partir du 1 f\u00E9vrier 2025."
    },
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Steven Veyt",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0419122548",
        "name": "KPMG Bedrijfsrevisoren",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027actionnaire unique d\u00E9cide de renouveler le mandat du commissaire KPMG Bedrijfsrevisoren, ayant son si\u00E8ge \u00E0 Luchthaven Brussel Nationaal 1K, 1930 Zaventem Belgique, repr\u00E9sent\u00E9e par Monsieur Steven Veyt, r\u00E9viseur d\u0027entreprises (A02579), et enregistr\u00E9e aupr\u00E8s de la Banque-Carrefour des Entreprises so"
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "David Lepoittevin",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-02-01",
      "evidence_quote": "Le conseil d\u0027administration d\u00E9cide, conform\u00E9ment \u00E0 l\u0027article 7:121 du Code des soci\u00E9t\u00E9s et des associations et \u00E0 l\u0027article 16 des statuts de la Soci\u00E9t\u00E9, de d\u00E9l\u00E9guer la gestion journali\u00E8re de la Soci\u00E9t\u00E9 ainsi que la repr\u00E9sentation de la Soci\u00E9t\u00E9 dans le cadre de cette gestion \u00E0 Monsieur David Lepoitte"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "PFIZER",
    "legal_form": "SA"
  }
}

{
  "facts": [
    {
      "date": "2024-08-23",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 23/08/2024",
      "value": "23/08/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "date": null,
      "type": "filing",
      "quote": "neergelegd/ontvangen op 19 JUNI 2024 ter griffie van de Nederlandstalige ondernemingsrechtbank Brussel",
      "value": "19/06/2024",
      "object": null,
      "subject": "e1",
      "date_suspect": "2024-06-19"
    },
    {
      "date": "2024-03-13",
      "type": "general_meeting",
      "quote": "BUITENGEWONE ALGEMENE VERGADERING VAN 13 MAART 2024",
      "value": "13/03/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-05-15",
      "type": "board_meeting",
      "quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 15 MEI 2024",
      "value": "15/05/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-03-13",
      "type": "officer_appointment",
      "quote": "Benoeming van: Bayer N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 1. AbbVie N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 2. Eli Lilly Benelux N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 3. Pfizer N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 4.GlaxoSmithKline Pharmaceuticals N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "bestuurder",
        "term": null,
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_resignation",
      "quote": "Ontslag van: 1. Takeda Belgium N.V.",
      "value": {
        "date": "2024-03-13",
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e7",
      "_value_raw": {
        "date": "13/03/2024",
        "role": "bestuurder"
      }
    },
    {
      "date": "2024-05-15",
      "type": "officer_appointment",
      "quote": "Op de Raad van Bestuur van 15 mei 2024 werd mevrouw An Van Gerven tot ondervoorzitter van de Raad van Bestuur benoemd.",
      "value": {
        "role": "ondervoorzitter van de Raad van Bestuur",
        "start_date": "2024-05-15"
      },
      "object": "e1",
      "subject": "e8",
      "_value_raw": {
        "role": "ondervoorzitter van de Raad van Bestuur",
        "term": null,
        "start_date": "15/05/2024"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "Bayer N.V. (BE 0404.754.571) heeft als vaste vertegenwoordiger de heer Werner De Prins.",
      "value": null,
      "object": "e2",
      "subject": "e12"
    },
    {
      "date": "2024-05-24",
      "type": "permanent_representative",
      "quote": "Sanofi Belgium N.V. (BE 0464.435.901) heeft als nieuwe vaste vertegenwoordiger vanaf 24/05/2024 de heer Bart Vermeulen in opvolging van de heer Johan Heylen.",
      "value": {
        "start_date": "24/05/2024"
      },
      "object": "e9",
      "subject": "e10"
    },
    {
      "date": "2024-06-14",
      "type": "permanent_representative",
      "quote": "Bayer N.V. (BE 0404.754.571) heeft als nieuwe vaste vertegenwoordiger vanaf 14/06/2024 de heer Niels Hessmann in opvolging van de heer Werner De Prins.",
      "value": {
        "start_date": "14/06/2024"
      },
      "object": "e2",
      "subject": "e13"
    },
    {
      "type": "statute_amendment",
      "quote": "De voorgestelde wijzigingen aan de statuten werden goedgekeurd door de Buitengewone Algemene Vergadering van 13 maart 2024",
      "value": null,
      "object": null,
      "subject": "e1"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "postfix": [
      "filing date 2024-06-19 outside [pub-60d, pub] -\u003E nulled (garbled stamp?)"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 27430,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Terhulpsesteenweg 166, 1170 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": "0404.754.571",
      "kind": "company",
      "name": "Bayer N.V.",
      "attrs": {
        "seat": "J.E. Mommaertslaan 14, 1831 Diegem"
      }
    },
    {
      "id": "e3",
      "kbo": "0845.096.860",
      "kind": "company",
      "name": "AbbVie N.V.",
      "attrs": {
        "seat": "avenue Einstein 14, 1300 Wavre"
      }
    },
    {
      "id": "e4",
      "kbo": "0406.754.454",
      "kind": "company",
      "name": "Eli Lilly Benelux N.V.",
      "attrs": {
        "seat": "Markiesstraat 1, 1000 Brussel"
      }
    },
    {
      "id": "e5",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer N.V.",
      "attrs": {
        "seat": "Pleinlaan 17, 1050 Elsene"
      }
    },
    {
      "id": "e6",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals N.V.",
      "attrs": {
        "seat": "avenue Fleming 20, 1300 Wavre"
      }
    },
    {
      "id": "e7",
      "kbo": "0403.054.202",
      "kind": "company",
      "name": "Takeda Belgium N.V.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "An Van Gerven",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium N.V.",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Bart Vermeulen",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Johan Heylen",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": null,
      "kind": "person",
      "name": "Werner De Prins",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Niels Hessmann",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: Nomination administrateurs - nomination vice-pr\u00E9sidente Conseil d\u0027administration - modifications aux statuts - nouveaux repr\u00E9sentants permanents des administrateurs",
      "value": "Nomination administrateurs - nomination vice-pr\u00E9sidente Conseil d\u0027administration - modifications aux statuts - nouveaux repr\u00E9sentants permanents des administrateurs",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-08-23",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 23/08/2024 - Annexes du Moniteur belge",
      "value": "23/08/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "date": null,
      "type": "filing",
      "quote": "neergelegd/ontvangen op 19 JUNI 2024",
      "value": "19/06/2024",
      "object": null,
      "subject": "e1",
      "date_suspect": "2024-06-19"
    },
    {
      "date": "2024-03-13",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE EXTRAORDINAIRE DU 13 MARS 2024",
      "value": "13/03/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-03-13",
      "type": "officer_appointment",
      "quote": "Nomination de : Bayer S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 1. AbbVie S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: ... 2. Eli Lilly Benelux S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: ... 3. Pfizer S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: ... 4.GlaxoSmithKline Pharmaceuticals S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2024-03-13"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "13/03/2024"
      }
    },
    {
      "date": "2024-03-13",
      "type": "officer_resignation",
      "quote": "D\u00E9mission de: 1. Takeda Belgium S.A.",
      "value": {
        "date": "2024-03-13",
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e7",
      "_value_raw": {
        "date": "13/03/2024",
        "role": "administrateur"
      }
    },
    {
      "date": "2024-03-13",
      "type": "statute_amendment",
      "quote": "Les modifications propos\u00E9es aux statuts ont \u00E9t\u00E9 approuv\u00E9es par l\u0027Assembl\u00E9e G\u00E9n\u00E9rale Extraordinaire du 13 mars 2024",
      "value": "Modifications aux statuts approuv\u00E9es par l\u0027AGE du 13 mars 2024 (articles 2, 5, 9, 12, 16, 28 et dispositions transitoires)",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-05-15",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 15 MAI 2024",
      "value": "15/05/2024",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2024-05-15",
      "type": "officer_appointment",
      "quote": "Lors du Conseil d\u0027administration du 15 mai 2024, Madame An Van Gerven a \u00E9t\u00E9 d\u00E9sign\u00E9e comme Vice-Pr\u00E9sidente.",
      "value": {
        "role": "Vice-Pr\u00E9sidente",
        "start_date": "2024-05-15"
      },
      "object": "e1",
      "subject": "e8",
      "_value_raw": {
        "role": "Vice-Pr\u00E9sidente",
        "start_date": "15/05/2024"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "Bayer S.A. (BE 0404.754.571) a d\u00E9sign\u00E9 comme repr\u00E9sentant permanent Monsieur Wemer De Prins.",
      "value": {
        "start_date": null
      },
      "object": "e2",
      "subject": "e9"
    },
    {
      "date": "2024-05-24",
      "type": "permanent_representative",
      "quote": "Sanofi Belgium S.A. (BE 0464.435.901) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 24/05/2024 Monsieur Bart Vermeulen, succ\u00E9dant \u00E0 Monsieur Johan Heylen.",
      "value": {
        "start_date": "24/05/2024"
      },
      "object": "e10",
      "subject": "e11"
    },
    {
      "date": "2024-06-14",
      "type": "permanent_representative",
      "quote": "Bayer S.A. (BE 0404.754.571) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 14/06/2024 Monsieur Niels Hessmann, succ\u00E9dant \u00E0 Monsieur Werner De Prins.",
      "value": {
        "start_date": "14/06/2024"
      },
      "object": "e2",
      "subject": "e13"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "postfix": [
      "filing date 2024-06-19 outside [pub-60d, pub] -\u003E nulled (garbled stamp?)"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 28008,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "org",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "seat": "chauss\u00E9e de La Hulpe 166, 1170 Bruxelles",
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e2",
      "kbo": "0404.754.571",
      "kind": "company",
      "name": "Bayer S.A.",
      "attrs": {
        "seat": "J..E. Mommaertslaan 14, 1831 Diegem"
      }
    },
    {
      "id": "e3",
      "kbo": "0845.096.860",
      "kind": "company",
      "name": "AbbVie S.A.",
      "attrs": {
        "seat": "avenue Einstein 14, 1300 Wavre"
      }
    },
    {
      "id": "e4",
      "kbo": "0406.754.454",
      "kind": "company",
      "name": "Eli Lilly Benelux S.A.",
      "attrs": {
        "seat": "rue du Marquis 1, 1000 Bruxelles"
      }
    },
    {
      "id": "e5",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer S.A.",
      "attrs": {
        "seat": "Boulevard de la Plaine 17, 1050 Ixelles"
      }
    },
    {
      "id": "e6",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals S.A.",
      "attrs": {
        "seat": "avenue Fleming 20, 1300 Wavre"
      }
    },
    {
      "id": "e7",
      "kbo": "0403.054.202",
      "kind": "company",
      "name": "Takeda Belgium S.A.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "An Van Gerven",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Werner De Prins",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium S.A.",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Bart Vermeulen",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": null,
      "kind": "person",
      "name": "Johan Heylen",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Niels Hessmann",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {
        "role": "CEO, charg\u00E9 de la gestion journali\u00E8re"
      }
    }
  ]
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Philippe Legrand",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-04-27",
      "evidence_quote": "De r\u00E9voquer le mandat accord\u00E9 \u00E0 Philippe Legrand, Tender Business Manager"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "V\u00E9ronique Gobiet",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-04-27",
      "evidence_quote": "De confirmer et nommer [...]: (1) Madame [...] V\u00E9ronique Gobiet, Category Lead Hospitals ... comme mandataires de la Soci\u00E9t\u00E9"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Micheline Vrancken",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-04-27",
      "evidence_quote": "De confirmer et nommer [...]: (2) Madame [...] Micheline Vrancken, Category Lead Rare Diseases ... comme mandataires de la Soci\u00E9t\u00E9"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Nathalie Gonnissen",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-04-27",
      "evidence_quote": "De confirmer et nommer [...]: (3) Madame [...] Nathalie Gonnissen, Category Lead Customer Experience Management ... comme mandataires de la Soci\u00E9t\u00E9"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Catherine P\u00E9lissier",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-04-27",
      "evidence_quote": "De confirmer et nommer [...]: (4) Madame [...] Catherine P\u00E9lissier, Category Lead Belux Oncology ... comme mandataires de la Soci\u00E9t\u00E9"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Ana Moreno Morales de Setien",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-04-27",
      "evidence_quote": "De confirmer et nommer [...]: (5) Madame [...] Ana Moreno Morales de Setien, Category Lead Primary Care ... comme mandataires de la Soci\u00E9t\u00E9"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Dimitri Galle",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-04-27",
      "evidence_quote": "De confirmer et nommer [...]: (6) Madame [...] Dimitri Galle, Category Lead Inflammation \u0026 Immunology Belux ... comme mandataires de la Soci\u00E9t\u00E9"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Machiel De Dauw",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-04-27",
      "evidence_quote": "De confirmer et nommer [...]: (7) Madame [...] Machiel De Dauw, Tender and Contracting Manager ... comme mandataires de la Soci\u00E9t\u00E9"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Kathleen Van der Slach",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-04-27",
      "evidence_quote": "De confirmer et nommer [...]: (8) Madame [...] Kathleen Van der Slach, Institution Commercial Office Operations Development ... comme mandataires de la Soci\u00E9t\u00E9"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "PFIZER",
    "legal_form": "SA"
  }
}

{
  "facts": [
    {
      "date": "2022-11-28",
      "type": "filing",
      "quote": "neergelegd/enwangen op 28 NOV. 2022",
      "value": "2022-11-28",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2022-08-01",
      "type": "permanent_representative",
      "quote": "Takeda Belgium N.V. ... heeft als nieuwe vaste vertegenwoordiger vanaf 01/08/2022 de heer Michael Nesrallah",
      "value": {
        "start_date": "2022-08-01"
      },
      "object": "e2",
      "subject": "e3"
    },
    {
      "date": "2022-11-01",
      "type": "permanent_representative",
      "quote": "Pfizer N.V. ... heeft als nieuwe vaste vertegenwoordiger vanaf 01/11/2022 mevrouw An Van Gerven",
      "value": {
        "start_date": "2022-11-01"
      },
      "object": "e4",
      "subject": "e5"
    },
    {
      "date": "2022-10-19",
      "type": "board_meeting",
      "quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 19 OKTOBER 2022",
      "value": "2022-10-19",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2022-10-19",
      "type": "officer_appointment",
      "quote": "Op de Raad van Bestuur van 19 oktober 2022 werd de heer Fr\u00E9d\u00E9ric Clais tot voorzitter van de Raad van Bestuur benoemd.",
      "value": {
        "role": "Voorzitter van de Raad van Bestuur",
        "start_date": "2022-10-19"
      },
      "object": "e1",
      "subject": "e6"
    },
    {
      "date": "2022-11-16",
      "type": "board_meeting",
      "quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 16 NOVEMBER 2022",
      "value": "2022-11-16",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2022-11-16",
      "type": "officer_appointment",
      "quote": "Op de Raad van Bestuur van 16 november 2022 werd mevrouw An Van Gerven tot ondervoorzitter van de Raad van Bestuur benoemd.",
      "value": {
        "role": "Ondervoorzitter van de Raad van Bestuur",
        "start_date": "2022-11-16"
      },
      "object": "e1",
      "subject": "e5"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1912,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Terhulpsesteenweg 166, 1170 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": "0403.054.202",
      "kind": "company",
      "name": "Takeda Belgium N.V.",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Michael Nesrallah",
      "attrs": {
        "address": "Eikenlaan 63, 1180 Ukkel",
        "birth_date": "1978-11-11",
        "birth_place": "Ottawa (Canada)"
      }
    },
    {
      "id": "e4",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer N.V.",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "An Van Gerven",
      "attrs": {
        "address": "Vinkenbosstraat 30, 3053 Haasrode",
        "birth_date": "1975-06-10",
        "birth_place": "Leuven"
      }
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "person",
      "name": "Fr\u00E9d\u00E9ric Clais",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte : Nouveaux repr\u00E9sentants permanents des administrateurs - Nomination pr\u00E9sident et vice-pr\u00E9sident",
      "value": "Nouveaux repr\u00E9sentants permanents des administrateurs - Nomination pr\u00E9sident et vice-pr\u00E9sident",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2022-11-28",
      "type": "filing",
      "quote": "Neergelegd/ontvangen op 28 NOV. 2022",
      "value": "2022-11-28",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2022-08-01",
      "type": "permanent_representative",
      "quote": "Takeda Belgium S.A. (BE 0403.054.202) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 01/08/2022 Monsieur Michael Nesrallah",
      "value": {
        "start_date": "2022-08-01"
      },
      "object": "e2",
      "subject": "e3"
    },
    {
      "date": "2022-11-01",
      "type": "permanent_representative",
      "quote": "Pfizer S.A. (BE 0401.994.823) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 01/11/2022 Madame An Van Gerven",
      "value": {
        "start_date": "2022-11-01"
      },
      "object": "e4",
      "subject": "e5"
    },
    {
      "date": "2022-10-19",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 19 OCTOBRE 2022",
      "value": "2022-10-19",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2022-10-19",
      "type": "officer_appointment",
      "quote": "Lors du Conseil d\u0027administration du 19 octobre 2022, Monsieur Fr\u00E9d\u00E9ric Clais a \u00E9t\u00E9 d\u00E9sign\u00E9 comme Pr\u00E9sident du Conseil d\u0027administration.",
      "value": {
        "role": "Pr\u00E9sident du Conseil d\u0027administration",
        "start_date": "2022-10-19"
      },
      "object": null,
      "subject": "e6"
    },
    {
      "date": "2022-11-16",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 16 NOVEMBRE 2022",
      "value": "2022-11-16",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2022-11-16",
      "type": "officer_appointment",
      "quote": "Lors du Conseil d\u0027administration du 16 novembre 2022, Madame An Van Gerven a \u00E9t\u00E9 d\u00E9sign\u00E9e comme Vice-Pr\u00E9sidente.",
      "value": {
        "role": "Vice-Pr\u00E9sidente",
        "start_date": "2022-11-16"
      },
      "object": null,
      "subject": "e5"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1899,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "seat": "chauss\u00E9e de La Hulpe 166, 1170 Bruxelles",
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e2",
      "kbo": "0403.054.202",
      "kind": "company",
      "name": "Takeda Belgium S.A.",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Michael Nesrallah",
      "attrs": {
        "address": "avenue des Ch\u00EAnes 63, 1180 Uccle",
        "birth_date": "1978-11-11",
        "birth_place": "Ottawa (Canada)"
      }
    },
    {
      "id": "e4",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer S.A.",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "An Van Gerven",
      "attrs": {
        "address": "Vinkenbosstraat 30, 3053 Haasrode",
        "birth_date": "1975-06-10",
        "birth_place": "Louvain"
      }
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "person",
      "name": "Fr\u00E9d\u00E9ric Clais",
      "attrs": {}
    }
  ]
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "An Van Gerven",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2022-09-01",
      "evidence_quote": "L\u0027actionnaire unique d\u00E9cide de nommer Mme An Van Gerven, \u00E9lisant domicile \u00E0 Vinkenbosstraat 30, 3053 Haasrode, Belgique, en qualit\u00E9 d\u0027administrateur de la Soci\u00E9t\u00E9, pour une p\u00E9riode de six ans et ce avec effet au 1er septembre 2022."
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "An Van Gerven",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2022-09-01",
      "evidence_quote": "Le conseil d\u0027administration d\u00E9cide de nommer An Van Gerven en tant qu\u0027un nouvel administrateur d\u00E9l\u00E9gu\u00E9 de la Soci\u00E9t\u00E9 charg\u00E9 de la gestion journali\u00E8re de la Soci\u00E9t\u00E9, conform\u00E9ment \u00E0 l\u0027article 7:121 du Code des soci\u00E9t\u00E9s et des associations et \u00E0 la repr\u00E9sentation de la Soci\u00E9t\u00E9 \u00E0 cet effet, et ce avec ef"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "PFIZER",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Olivier Declercq",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0419122548",
        "name": "KPMG R\u00E9viseurs d\u0027Entreprises SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027actionnaire unique d\u00E9cide de renouveler le mandat de KPMG R\u00E9viseurs d\u0027Entreprises SRL, dont le si\u00E8ge est \u00E9tabli Luchthaven Brussel Nationaal 1K \u00E0 1930 Zaventem (Belgique), repr\u00E9sent\u00E9e par Monsieur Olivier Declercq, r\u00E9viseur d\u0027entreprise (A02076), et enregistr\u00E9e aupr\u00E8s de la Banque-Carrefour des En"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "PFIZER",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Guy Van den Meersche",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-05-18",
      "evidence_quote": "L\u0027actionnaire unique d\u00E9cide de nommer, avec effet imm\u00E9diat, les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9 et pour une dur\u00E9e de six ans: -Monsieur Guy Van den Meersche, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Anne De Backer",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-05-18",
      "evidence_quote": "L\u0027actionnaire unique d\u00E9cide de nommer, avec effet imm\u00E9diat, les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9 et pour une dur\u00E9e de six ans: ... -Madame Anne De Backer, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "PFIZER",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Guy Van den Meersche",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-05-18",
      "evidence_quote": "L\u0027actionnaire unique d\u00E9cide de nommer, avec effet imm\u00E9diat, les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9 et pour une dur\u00E9e de six ans: -Monsieur Guy Van den Meersche, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Anne De Backer",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-05-18",
      "evidence_quote": "L\u0027actionnaire unique d\u00E9cide de nommer, avec effet imm\u00E9diat, les personnes suivantes en qualit\u00E9 d\u0027administrateurs de la Soci\u00E9t\u00E9 et pour une dur\u00E9e de six ans: ... -Madame Anne De Backer, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "PFIZER",
    "legal_form": "SA"
  }
}

{
  "facts": [
    {
      "date": "2021-04-30",
      "type": "publication",
      "quote": "23 APR. 2021",
      "value": "2021-04-23",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-04-23",
      "type": "filing",
      "quote": "neergelegd/ontvangen op ... 23 APR. 2021",
      "value": "2021-04-23",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-03-17",
      "type": "general_meeting",
      "quote": "ALGEMENE VERGADERING VAN 17 MAART 2021",
      "value": "2021-03-17",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-03-17",
      "type": "officer_appointment",
      "quote": "Benoeming van: 1. Takeda Belgium N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 1. AbbVie N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e3"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 2. Amgen N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e4"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 3. Eli Lilly Benelux N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e5"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 4. Pfizer N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e6"
    },
    {
      "type": "officer_resignation",
      "quote": "Ontslag van: 1. Merck N.V.",
      "value": {
        "role": "bestuurder",
        "end_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e7"
    },
    {
      "type": "permanent_representative",
      "quote": "Takeda Belgium NV heeft als vaste vertegenwoordiger de heer Laurerit Henaux",
      "value": null,
      "object": "e2",
      "subject": "e8"
    },
    {
      "type": "officer_appointment",
      "quote": "Caroline Ven CEO, belast met het dagelijks bestuur",
      "value": {
        "role": "CEO, belast met het dagelijks bestuur"
      },
      "object": "e1",
      "subject": "e9"
    }
  ],
  "act_meta": {
    "outcome": "review",
    "postfix": [
      "publication date 2021-04-23 -\u003E edition 2021-04-30"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1820,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Terhulpsesteenweg 166, 1170 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": "0403.054.202",
      "kind": "company",
      "name": "Takeda Belgium N.V.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
      }
    },
    {
      "id": "e3",
      "kbo": "0845.096.860",
      "kind": "company",
      "name": "AbbVie N.V.",
      "attrs": {
        "seat": "avenue Einstein 14, 1300 Wavre"
      }
    },
    {
      "id": "e4",
      "kbo": "0439.652.401",
      "kind": "company",
      "name": "Amgen N.V.",
      "attrs": {
        "seat": "Telecomlaan 5-7, 1831 Diegem"
      }
    },
    {
      "id": "e5",
      "kbo": "0406.754.454",
      "kind": "company",
      "name": "Eli Lilly Benelux N.V.",
      "attrs": {
        "seat": "Markiesstraat 1, 1000 Brussel"
      }
    },
    {
      "id": "e6",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer N.V.",
      "attrs": {
        "seat": "Pleinlaan 17, 1050 Elsene"
      }
    },
    {
      "id": "e7",
      "kbo": "0403.047.965",
      "kind": "company",
      "name": "Merck N.V.",
      "attrs": {
        "seat": "Brusselsesteenweg 288, 3090 Overijse"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "flag": "Name \u0027Laurerit\u0027 appears to be an OCR error for \u0027Laurent\u0027, but preserved as printed.",
      "kind": "person",
      "name": "Laurerit Henaux",
      "attrs": {
        "address": "avenue des B\u00E9cassines 26, 1160 Brussel",
        "birth_date": "1966-04-27",
        "birth_place": "Toulouse (Frankrijk)"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {
        "role": "CEO, belast met het dagelijks bestuur"
      }
    }
  ]
}

{
  "facts": [
    {
      "date": "2021-04-30",
      "type": "publication",
      "quote": "1/2021",
      "value": "2021-01-01",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-04-23",
      "type": "filing",
      "quote": "neergelegd/ontvangen op 23 APR. 2021",
      "value": "2021-04-23",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-03-17",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE DU 17 MARS 2021",
      "value": "2021-03-17",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2021-03-17",
      "type": "officer_appointment",
      "quote": "Nomination de: 1. Takeda Belgium S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 1. AbbVie S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e3"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 2. Amgen S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e4"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 3. Eli Lilly Benelux S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e5"
    },
    {
      "date": "2021-03-17",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 4. Pfizer S.A.",
      "value": {
        "role": "administrateur",
        "start_date": "2021-03-17"
      },
      "object": "e1",
      "subject": "e6"
    },
    {
      "date": "2021-03-17",
      "type": "officer_resignation",
      "quote": "D\u00E9mission de : 1. Merck S.A.",
      "value": {
        "date": "2021-03-17",
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e7"
    },
    {
      "type": "permanent_representative",
      "quote": "Takeda Belgium a d\u00E9sign\u00E9 comme repr\u00E9sentant permanent Monsieur Laurent Henaux",
      "value": null,
      "object": "e2",
      "subject": "e8"
    }
  ],
  "act_meta": {
    "outcome": "review",
    "postfix": [
      "publication date 2021-01-01 -\u003E edition 2021-04-30"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1896,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "org",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "seat": "chauss\u00E9e de La Hulpe 166, 1170 Bruxelles",
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e2",
      "kbo": "0403.054.202",
      "kind": "company",
      "name": "Takeda Belgium S.A.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
      }
    },
    {
      "id": "e3",
      "kbo": "0845.096.860",
      "kind": "company",
      "name": "AbbVie S.A.",
      "attrs": {
        "seat": "avenue Einstein 14, 1300 Wavre"
      }
    },
    {
      "id": "e4",
      "kbo": "0439.652.401",
      "kind": "company",
      "name": "Amgen S.A.",
      "attrs": {
        "seat": "Telecomlaan 5-7, 1831 Diegem"
      }
    },
    {
      "id": "e5",
      "kbo": "0406.754.454",
      "kind": "company",
      "name": "Eli Lilly Benelux S.A.",
      "attrs": {
        "seat": "rue du Marquis 1, 1000 Bruxelles"
      }
    },
    {
      "id": "e6",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer S.A.",
      "attrs": {
        "seat": "boulevard de la Plaine 17, 1050 Ixelles"
      }
    },
    {
      "id": "e7",
      "kbo": "0403.047.965",
      "kind": "company",
      "name": "Merck S.A.",
      "attrs": {
        "seat": "Brusselsesteenweg 288, 3090 Overijse"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Laurent Henaux",
      "attrs": {
        "address": "avenue des B\u00E9cassines 26, 1160 Bruxelles",
        "birth_date": "1966-04-27",
        "birth_place": "Toulouse (France)"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {
        "role": "CEO, charg\u00E9 de la gestion journali\u00E8re"
      }
    }
  ]
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2020-04-30",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "PFIZER",
    "legal_form": "SA"
  },
  "signature_regime": "joint_two",
  "special_mandates": [
    {
      "quote": "L\u0027assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 Erwin Simons, Frederik Verhaeghe, Gieljan Van de Velde et tout autre avocat ou collaborateur de DLA Piper, \u00E0 1050 Bruxelles, Avenue Louise 106, chacun agissant s\u00E9par\u00E9ment, ainsi qu\u0027\u00E0 leurs employ\u00E9s, pr\u00E9pos\u00E9s et mandataires, avec droit de substitution, afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u0027entreprise en vue d\u0027assurer l\u0027inscription/la modification des donn\u00E9es dans la Banque Carrefour des Entreprises et, le cas \u00E9ch\u00E9ant, aupr\u00E8s de l\u0027Administration de la Taxe sur la Valeur Ajout\u00E9e.",
      "holder_kbo": null,
      "holder_name": "DLA Piper",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "PFIZER",
    "legal_form": "SA"
  }
}

{
  "stage": null,
  "notary": {
    "name": "Ilse Berlamont",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2020-02-19",
    "filing_date": "2020-01-21",
    "act_kind_objet": "Distribution d\u0027un dividende interm\u00E9diaire"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2020-01-21",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0401.994.823",
        "name": "Pfizer",
        "role": "other",
        "address": "Boulevard de la Plaine 17, 1050 Bruxelles",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Le dividende interm\u00E9diaire de 50.000.000 EUR est distribu\u00E9 \u00E0 l\u0027actionnaire unique de la soci\u00E9t\u00E9. Aucun transfert de patrimoine n\u0027est effectu\u00E9.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "Pfizer",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Ilse Berlamont",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027actionnaire unique de la soci\u00E9t\u00E9 anonyme Pfizer a d\u00E9cid\u00E9, par proc\u00E8s-verbal en date du 21 janvier 2020, de distribuer un dividende interm\u00E9diaire brut de 50.000.000 EUR, imm\u00E9diatement payable. Il a \u00E9galement d\u00E9l\u00E9gu\u00E9 des pouvoirs sp\u00E9ciaux \u00E0 plusieurs avocats pour assurer la publication des d\u00E9cisions aux Annexes du Moniteur belge, mettre \u00E0 jour l\u0027inscription de la soci\u00E9t\u00E9 \u00E0 la Banque Carrefour des Entreprises et accomplir toutes les d\u00E9marches n\u00E9cessaires.",
  "co_filed_documents": [
    "Formulaires de publication I et II"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "capital_shares"
}

{
  "stage": null,
  "notary": {
    "name": "Karel Van De Sompel",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2019-07-10",
    "filing_date": "2019-06-03",
    "act_kind_objet": "Communication en application de l\u0027article 646, \u00A7 2 du Code des soci\u00E9t\u00E9s"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2019-06-03",
    "unanimous": null
  },
  "conversion": {
    "effective_date": null,
    "jurisdiction_to": null,
    "legal_form_after": null,
    "jurisdiction_from": null,
    "legal_form_before": "SA"
  },
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": null,
        "name": "Pfizer International Markets B.V.",
        "role": "acquiring",
        "address": "Rivium Westlaan 142, 2909 LD Capelle aan den IJssel, Pays-Bas",
        "is_foreign": true,
        "legal_form": "BV",
        "is_new_company": false,
        "jurisdiction_country": "NL"
      },
      {
        "kbo": "0401.994.823",
        "name": "Pfizer",
        "role": "absorbed",
        "address": "Boulevard de la Plaine, 17 \u00E0 1050 Bruxelles",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:7",
      "12:50"
    ],
    "is_cross_border": true,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Le patrimoine entier de la soci\u00E9t\u00E9 anonyme Pfizer a \u00E9t\u00E9 transf\u00E9r\u00E9 \u00E0 Pfizer International Markets B.V., qui est devenue son seul actionnaire. L\u0027op\u00E9ration s\u0027est faite sans \u00E9mission de nouveaux titres.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "Pfizer",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Karel Van De Sompel",
    "org_rep_person_name": null
  },
  "summary_narrative": "La soci\u00E9t\u00E9 anonyme Pfizer, dont le si\u00E8ge est \u00E0 Bruxelles, a \u00E9t\u00E9 absorb\u00E9e par Pfizer International Markets B.V., soci\u00E9t\u00E9 n\u00E9erlandaise, en date du 3 juin 2019. Cette op\u00E9ration, qualifi\u00E9e de fusion silencieuse, s\u0027est faite sans \u00E9mission de nouveaux titres, car la soci\u00E9t\u00E9 n\u00E9erlandaise \u00E9tait d\u00E9j\u00E0 d\u00E9tentrice de tous les actions de Pfizer.",
  "co_filed_documents": [],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "director_changes"
}

{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Karel Van De Sompel",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-05-15",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide, \u00E0 l\u0027unanimit\u00E9, de r\u00E9\u00E9lire \u00E0 partir de ce jour: -Monsieur Karel Van De Sompel; ... comme administrateurs de la soci\u00E9t\u00E9 pour une dur\u00E9e de six ans."
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Didier Vinel",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-05-15",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide, \u00E0 l\u0027unanimit\u00E9, de r\u00E9\u00E9lire \u00E0 partir de ce jour: ... -Monsieur Didier Vinel; ... comme administrateurs de la soci\u00E9t\u00E9 pour une dur\u00E9e de six ans."
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Laurence Einweller",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-05-15",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide, \u00E0 l\u0027unanimit\u00E9, de r\u00E9\u00E9lire \u00E0 partir de ce jour: ... -Madame Laurence Einweller. comme administrateurs de la soci\u00E9t\u00E9 pour une dur\u00E9e de six ans."
    },
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Olivier Declercq",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "KPMG R\u00E9viseurs d\u0027Entreprises",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2019-05-15",
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide, \u00E0 l\u0027unanimit\u00E9, de r\u00E9\u00E9lire KPMG R\u00E9viseurs d\u0027Entreprises, dont le si\u00E8ge social se situe Luchthaven Brussel Nationaal, 1K \u00E0 B-1930 Zaventem, repr\u00E9sent\u00E9 par son repr\u00E9sentant permanent Monsieur Olivier Declercq, en qualit\u00E9 de commissaire de la soci\u00E9t\u00E9 pour une dur\u00E9e de trois "
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "PFIZER",
    "legal_form": "SA"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "PFIZER",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 10666355,
      "currency": "EUR",
      "after_eur": 39604969.01,
      "delta_eur": 10666355.0,
      "before_eur": 28938614.01,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2019-02-25",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide, suite \u00E0 la d\u00E9cision de fusion par absorption, d\u0027augmenter le capital \u00E0 concurrence d\u0027un montant de 10.666.355 EUR pour le porter de 28.938.614,01 EUR \u00E0 39.604.969,01 EUR, par la cr\u00E9ation de 66.895 nouvelles actions, enti\u00E8rement lib\u00E9r\u00E9es",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "PFIZER",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Catherine P\u00E9lissier",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-01-01",
      "evidence_quote": "De r\u00E9voquer les mandats accord\u00E9s \u00E0 Catherine P\u00E9lissier et An Van Gerven respectivement par Conseil d\u0027administration du 25 janvier 2016."
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "An Van Gerven",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-01-01",
      "evidence_quote": "De r\u00E9voquer les mandats accord\u00E9s \u00E0 Catherine P\u00E9lissier et An Van Gerven respectivement par Conseil d\u0027administration du 25 janvier 2016."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "V\u00E9ronique Gobiet",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-01-01",
      "evidence_quote": "de confirmer et nommer: (1) Madame V\u00E9ronique Gobiet, Hospital Lead BeLux ... le comme mandataires de la Soci\u00E9t\u00E9"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Micheline Vrancken",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-01-01",
      "evidence_quote": "de confirmer et nommer: (2) Madame Micheline Vrancken, RD Lead Belux ... le comme mandataires de la Soci\u00E9t\u00E9"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Nathalie Gonnissen",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-01-01",
      "evidence_quote": "de confirmer et nommer: (3) Madame Nathalie Gonnissen, 1\u0026l Lead Belux ... le comme mandataires de la Soci\u00E9t\u00E9"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Catherine P\u00E9lissier",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-01-01",
      "evidence_quote": "de confirmer et nommer: (4) Madame Catherine P\u00E9lissier, Oncology Lead Belux ... le comme mandataires de la Soci\u00E9t\u00E9"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Ana Moreno De Setien",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-01-01",
      "evidence_quote": "de confirmer et nommer: (5) Madame Ana Moreno De Setien, Vaccines Lead Belux ... le comme mandataires de la Soci\u00E9t\u00E9"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "PFIZER",
    "legal_form": "SA"
  }
}

{
  "stage": "proposal",
  "notary": {
    "name": "Erwin Simons",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2019-01-22",
    "filing_date": "2019-01-10",
    "act_kind_objet": "D\u00E9p\u00F4t du projet de fusion"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2019-01-09",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": {
    "summary": "Les rapports sp\u00E9ciaux sont renonc\u00E9s par les associ\u00E9s et actionnaires de PF OFG et de Pfizer SA, conform\u00E9ment \u00E0 l\u0027article 694 du Code des soci\u00E9t\u00E9s, en raison de l\u0027approbation \u00E0 l\u0027unanimit\u00E9 de la fusion.",
    "articles": [
      "5:121",
      "12:26 \u00A71"
    ]
  },
  "restructuring": {
    "parties": [
      {
        "kbo": "0707.924.608",
        "name": "PF OFG Belgium SPRL",
        "role": "absorbed",
        "address": "Boulevard de la Plaine 17, 1050 Ixelles",
        "is_foreign": false,
        "legal_form": "SPRL",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": "0401.994.823",
        "name": "Pfizer SA",
        "role": "acquiring",
        "address": "Boulevard de la Plaine 17, 1050 Ixelles",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": "0552.558.025",
        "name": "Pfizer PFE Belgium SPRL",
        "role": "demerged",
        "address": "Boulevard de la Plaine 17, 1050 Ixelles",
        "is_foreign": false,
        "legal_form": "SPRL",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": 0.0000119094,
    "legal_articles": [
      "12:7",
      "12:50",
      "671",
      "693",
      "694",
      "695"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2018-11-30",
    "exchange_ratio_text": "1 action de PSA pour environ 83.960 parts sociales de PF OFG",
    "new_shares_issued_n": 66895,
    "real_estate_included": false,
    "patrimony_description": "Le patrimoine transf\u00E9r\u00E9 comprend l\u0027ensemble des activit\u00E9s li\u00E9es \u00E0 l\u0027IMB Business (business innovant, biosimilaires, produits anti-infectieux hospitaliers, st\u00E9riles) transf\u00E9r\u00E9 de Pfizer PFE Belgium SPRL \u00E0 PF OFG Belgium SPRL via une scission partielle, puis transf\u00E9r\u00E9 \u00E0 Pfizer SA via une fusion par absorption.",
    "equity_transferred_eur": 56018500.0,
    "accounting_effective_date": "2019-02-25"
  },
  "subject_company": {
    "kbo": "0401.994.823",
    "name_full": "Pfizer",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Erwin Simons",
    "org_rep_person_name": null
  },
  "summary_narrative": "Ce projet de fusion par absorption vise \u00E0 int\u00E9grer PF OFG Belgium SPRL dans Pfizer SA, apr\u00E8s une scission partielle pr\u00E9alable du \u0027IMB Business\u0027 de Pfizer PFE Belgium SPRL. L\u0027op\u00E9ration fait partie d\u0027une r\u00E9organisation internationale du groupe Pfizer, visant \u00E0 concentrer les activit\u00E9s strat\u00E9giques : Pfizer SA se concentrera sur les activit\u00E9s innovantes, tandis que Pfizer PFE se concentrera sur les m\u00E9dicaments \u00E9tablis. La fusion est conditionn\u00E9e \u00E0 l\u0027approbation de la scission partielle et sera approuv\u00E9e par les assembl\u00E9es g\u00E9n\u00E9rales extraordinaires des soci\u00E9t\u00E9s concern\u00E9es.",
  "co_filed_documents": [],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "facts": [
    {
      "date": "2018-07-09",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 09/07/2018",
      "value": "09/07/2018",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2018-06-20",
      "type": "filing",
      "quote": "neergelegd/onvangen od 20 JUM 2018",
      "value": "20/06/2018",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2018-03-23",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE DU 23 MARS 2018",
      "value": "23/03/2018",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2018-03-23",
      "type": "officer_appointment",
      "quote": "Nomination de : 1. Amgen S.A.",
      "value": {
        "role": "Membre du Conseil d\u0027administration",
        "start_date": "2018-03-23"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "Membre du Conseil d\u0027administration",
        "term": null,
        "start_date": "23/03/2018"
      }
    },
    {
      "date": "2018-03-23",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 1. AbbVie S.A.",
      "value": {
        "role": "Membre du Conseil d\u0027administration",
        "start_date": "2018-03-23"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "Membre du Conseil d\u0027administration",
        "term": null,
        "start_date": "23/03/2018"
      }
    },
    {
      "date": "2018-03-23",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 2. Celgene S.P.R.L.",
      "value": {
        "role": "Membre du Conseil d\u0027administration",
        "start_date": "2018-03-23"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "Membre du Conseil d\u0027administration",
        "term": null,
        "start_date": "23/03/2018"
      }
    },
    {
      "date": "2018-03-23",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 3. Eli Lilly Benelux S.A.",
      "value": {
        "role": "Membre du Conseil d\u0027administration",
        "start_date": "2018-03-23"
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": {
        "role": "Membre du Conseil d\u0027administration",
        "term": null,
        "start_date": "23/03/2018"
      }
    },
    {
      "date": "2018-03-23",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 4. Pfizer S.A.",
      "value": {
        "role": "Membre du Conseil d\u0027administration",
        "start_date": "2018-03-23"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "Membre du Conseil d\u0027administration",
        "term": null,
        "start_date": "23/03/2018"
      }
    },
    {
      "date": "2018-03-23",
      "type": "officer_resignation",
      "quote": "D\u00E9mission de: 1. Boehringer Ingelheim SCS",
      "value": {
        "date": "2018-03-23",
        "role": "Membre du Conseil d\u0027administration"
      },
      "object": "e1",
      "subject": "e7",
      "_value_raw": {
        "date": "23/03/2018",
        "role": "Membre du Conseil d\u0027administration"
      }
    },
    {
      "date": "2018-05-30",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 30 MAI 2018",
      "value": "30/05/2018",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2018-05-30",
      "type": "officer_appointment",
      "quote": "Pfizer ... a \u00E9t\u00E9 \u00E9lue pr\u00E9sident ... pour un mandat de deux ans",
      "value": {
        "role": "Pr\u00E9sident du Conseil d\u0027administration",
        "term": "deux ans",
        "start_date": "2018-05-30"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "Pr\u00E9sident du Conseil d\u0027administration",
        "term": "deux ans",
        "start_date": "30/05/2018"
      }
    },
    {
      "date": "2018-05-30",
      "type": "officer_appointment",
      "quote": "MSD Belgium ... a \u00E9t\u00E9 \u00E9lue Vice-Pr\u00E9sident ... pour un mandat de deux ans",
      "value": {
        "role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
        "term": "deux ans",
        "start_date": "2018-05-30"
      },
      "object": "e1",
      "subject": "e8",
      "_value_raw": {
        "role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
        "term": "deux ans",
        "start_date": "30/05/2018"
      }
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1885,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "org",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "seat": "chauss\u00E9e de La Hulpe 166, 1170 BRUXELLES",
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e2",
      "kbo": "0439.652.401",
      "kind": "company",
      "name": "Amgen S.A.",
      "attrs": {
        "seat": "Telecomlaan 5-7, 1831 Diegem"
      }
    },
    {
      "id": "e3",
      "kbo": "0845.096.860",
      "kind": "company",
      "name": "AbbVie S.A.",
      "attrs": {
        "seat": "avenue Einstein 14, 1300 Wavre"
      }
    },
    {
      "id": "e4",
      "kbo": "0882.012.387",
      "kind": "company",
      "name": "Celgene S.P.R.L.",
      "attrs": {
        "seat": "Place du Luxembourg 1, 1420 Braine-l\u0027Alleud"
      }
    },
    {
      "id": "e5",
      "kbo": "0406.754.454",
      "kind": "company",
      "name": "Eli Lilly Benelux S.A.",
      "attrs": {
        "seat": "rue du Marquis 1, 1000 Bruxelles"
      }
    },
    {
      "id": "e6",
      "kbo": "0401.994.823",
      "kind": "company",
      "name": "Pfizer S.A.",
      "attrs": {
        "seat": "boulevard de la Plaine 17, 1050 Ixelles"
      }
    },
    {
      "id": "e7",
      "kbo": "0435.953.632",
      "kind": "company",
      "name": "Boehringer Ingelheim SCS",
      "attrs": {
        "seat": "avenue Ariane 16, 1200 Woluwe-Saint-Lambert"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "company",
      "name": "MSD Belgium",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Karel Van De Sompel",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Clarisse Lhoste",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Catherine Rutten",
      "attrs": {}
    }
  ]
}